These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. No gain, no pain: NaV1.7 as an analgesic target. King GF; Vetter I ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714 [TBL] [Abstract][Full Text] [Related]
6. Future potential and status of selective sodium channel blockers for the treatment of pain. Priest BT Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626 [TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacology of analgesics: outlook and risks]. Beubler E Internist (Berl); 2005 Oct; 46(10):1076, 1078-80, 1082-6. PubMed ID: 16034581 [TBL] [Abstract][Full Text] [Related]
8. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula. Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258 [TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of ProTx-III [μ-TRTX-Tp1a], a New Voltage-Gated Sodium Channel Inhibitor from Venom of the Tarantula Thrixopelma pruriens. Cardoso FC; Dekan Z; Rosengren KJ; Erickson A; Vetter I; Deuis JR; Herzig V; Alewood PF; King GF; Lewis RJ Mol Pharmacol; 2015 Aug; 88(2):291-303. PubMed ID: 25979003 [TBL] [Abstract][Full Text] [Related]
12. Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain. Chowdhury S; Chafeev M; Liu S; Sun J; Raina V; Chui R; Young W; Kwan R; Fu J; Cadieux JA Bioorg Med Chem Lett; 2011 Jun; 21(12):3676-81. PubMed ID: 21570288 [TBL] [Abstract][Full Text] [Related]
13. Cancer pain relief in Paraiba, Brazil. Tróccoli BT; Keller ML J Pain Symptom Manage; 1989 Sep; 4(3):110-1. PubMed ID: 2778357 [No Abstract] [Full Text] [Related]
15. Trends in Pain Medication Initiation Among Patients With Newly Diagnosed Diabetic Peripheral Neuropathy, 2014-2018. Fan J; Jeffery MM; Hooten WM; Shah ND; McCoy RG JAMA Netw Open; 2021 Jan; 4(1):e2035632. PubMed ID: 33507254 [TBL] [Abstract][Full Text] [Related]
16. Isoform-selective voltage-gated Na(+) channel modulators as next-generation analgesics. England S; Rawson D Future Med Chem; 2010 May; 2(5):775-90. PubMed ID: 21426202 [TBL] [Abstract][Full Text] [Related]
17. [Useful guideline for treatment of pain in vulnerable elderly people]. van Kleef M; Geurts JW Ned Tijdschr Geneeskd; 2012; 155(35):A4933. PubMed ID: 22929752 [TBL] [Abstract][Full Text] [Related]
18. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE. Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073 [TBL] [Abstract][Full Text] [Related]
19. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats. Lindia JA; Köhler MG; Martin WJ; Abbadie C Pain; 2005 Sep; 117(1-2):145-53. PubMed ID: 16061326 [TBL] [Abstract][Full Text] [Related]
20. [Palliative medicine--state of the art]. Korb G Urologe A; 2007 Jan; 46(1):5-6. PubMed ID: 17211643 [No Abstract] [Full Text] [Related] [Next] [New Search]